Texas Top Legal Officer Sues Acetaminophen Producers Over Autism Spectrum Claims
The top legal official in Texas Paxton is filing a lawsuit against the producers of acetaminophen, alleging the corporations hid alleged dangers that the drug presented to pediatric neurological development.
The lawsuit arrives a month after Donald Trump advocated an unverified association between using Tylenol - referred to as acetaminophen - during pregnancy and autism spectrum disorder in young ones.
The attorney general is taking legal action against Johnson & Johnson, which formerly manufactured the medication, the sole analgesic approved for expectant mothers, and the current manufacturer, which currently produces it.
In a declaration, he stated they "betrayed America by profiting off of discomfort and pushing pills regardless of the dangers."
The company says there is no credible evidence tying Tylenol to autism.
"These companies misled for generations, knowingly endangering numerous people to line their pockets," the attorney general, from the Republican party, said.
The company said in a statement that it was "seriously troubled by the perpetuation of misinformation on the safety of paracetamol and the potential impact that could have on the well-being of women and children in America."
On its online platform, Kenvue also mentioned it had "continuously evaluated the relevant science and there is lacking reliable evidence that shows a verified association between consuming paracetamol and autism."
Groups representing medical professionals and healthcare providers share this view.
The American College of Obstetricians and Gynecologists has declared paracetamol - the primary component in acetaminophen - is among limited choices for women during pregnancy to address pain and elevated temperature, which can create major wellness concerns if not addressed.
"In more than two decades of investigation on the use of acetaminophen in pregnancy, not a single reputable study has successfully concluded that the use of paracetamol in any stage of pregnancy results in neurological conditions in young ones," the group commented.
This legal action mentions recent announcements from the former administration in arguing the drug is reportedly hazardous.
In recent weeks, Trump caused concern from health experts when he instructed expectant mothers to "resist strongly" not to take Tylenol when ill.
Federal regulators then issued a notice that medical professionals should contemplate reducing the consumption of acetaminophen, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in children has not been proven.
The Health Department head RFK Jr, who supervises the FDA, had vowed in spring to conduct "comprehensive study program" that would determine the cause of autism spectrum disorder in a matter of months.
But specialists warned that finding a single cause of autism - thought by researchers to be the consequence of a intricate combination of inherited and external influences - would prove challenging.
Autism spectrum disorder is a type of permanent neurological difference and impairment that influences how individuals experience and relate to the world, and is identified using medical professional evaluations.
In his lawsuit, Paxton - who supports Trump who is campaigning for the Senate - claims the manufacturer and J&J "deliberately disregarded and sought to suppress the research" around acetaminophen and autism.
The case aims to force the companies "eliminate any marketing or advertising" that claims acetaminophen is secure for expectant mothers.
The court case echoes the grievances of a assembly of guardians of children with autism and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in two years ago.
A federal judge threw out the legal action, declaring studies from the family's specialists was lacking definitive proof.